08:00 , Mar 5, 2012 |  BC Week In Review  |  Company News

BioConnections, Hebrew University of Jerusalem sales and marketing update

The university's Yissum Research Development Company Ltd. tech transfer arm granted BioConnections exclusive, worldwide rights to commercialize kits that enable immediate detection of all multidrug resistant (MDR) and extremely drug resistant (XDR) infections, including bacterial...